Child-Parent Screening for Familial Hypercholesterolemia - 11/10/11
Doi : 10.1016/j.jpeds.2011.06.006
David S. Wald, MD a, ⁎ 
, Anuradhani Kasturiratne, MD a, Angela Godoy, BSc a, Louise Ma, MD b, Jonathan P. Bestwick, MSc a, Nick Brewer, MD c, Nicholas J. Wald, FRS a
, Anuradhani Kasturiratne, MD a, Angela Godoy, BSc a, Louise Ma, MD b, Jonathan P. Bestwick, MSc a, Nick Brewer, MD c, Nicholas J. Wald, FRS a a Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
b Whittingdon Hospital, London, United Kingdom
c Lower Clapton Group Practice, London, United Kingdom
Reprint requests: David S. Wald, MD, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, United Kingdom.Abstract |
A pilot study of child-parent screening for familial hypercholesterolemia was undertaken in children aged 1 to 2 years coming for immunization. Of 214 parents asked, 200 agreed to screening (94%). Simultaneous immunization-cholesterol measurement was successful in all children. Population child-parent screening is feasible and acceptable when combined with pediatric immunization.
Le texte complet de cet article est disponible en PDF.Mots-clés : FH, MoM
Plan
| Funded by a grant from the British Medical Association. Alere Ltd provided the Cholestech analyzer for cholesterol measurement, and Elitech UK Ltd provided the Tenderfoot lancets. Neither the funder nor industry had any role in the design, conduct, or writing up of the study. D.W. has a patent (GB2414186A) for a medical device that combines medical injection and blood sampling. The remaining authors authors declare no conflicts of interest. |
© 2011
Mosby, Inc. Tous droits réservés.
Vol 159 - N° 5
P. 865-867 - novembre 2011 Retour au numéro
Article précédent
- Cardiac Disease in Methylmalonic Acidemia
- Carlos E. Prada, Fatma Al Jasmi, Edwin P. Kirk, Maxwell Hopp, Owen Jones, Nancy D. Leslie, T. Andrew Burrow
- Positive Nikolsky Sign due to Staphylococcal Scaled Skin Syndrome
- Rafik Bourayou, Nolwenn Le Sache, Isabelle Kone-Paut
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?